High-Throughput Assay for the Identification of Compounds Regulating Osteogenic Differentiation of Human Mesenchymal Stromal Cells
Open Access
- 26 October 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (10), e26678
- https://doi.org/10.1371/journal.pone.0026678
Abstract
Human mesenchymal stromal cells are regarded as the golden standard for cell-based therapies. They present multilineage differentiation potential and trophic and immunosuppressive abilities, making them the best candidate for clinical applications. Several molecules have been described to increase bone formation and were mainly discovered by candidate approaches towards known signaling pathways controlling osteogenesis. However, their bone forming potential is still limited, making the search for novel molecules a necessity. High-throughput screening (HTS) not only allows the screening of a large number of diverse chemical compounds, but also allows the discovery of unexpected signaling pathways and molecular mechanisms for a certain application, even without the prior knowledge of the full molecular pathway. Typically HTS is performed in cell lines, however, in this manuscript we have performed a phenotypical screen on more clinically relevant human mesenchymal stromal cells, as a proof of principle that HTS can be performed in those cells and can be used to find small molecules that impact stem cell fate. From a library of pharmacologically active small molecules, we were able to identify novel compounds with increased osteogenic activity. These compounds allowed achieving levels of bone-specific alkaline phosphatase higher than any other combination previously known. By combining biochemical techniques, we were able to demonstrate that a medium to high-throughput phenotypic assay can be performed in academic research laboratories allowing the discovery of novel molecules able to enhance stem cell differentiation.This publication has 41 references indexed in Scilit:
- A link between the accumulation of DNA damage and loss of multi‐potency of human mesenchymal stromal cellsJournal of Cellular and Molecular Medicine, 2010
- Wnt/β-Catenin Signaling Enhances Osteoblastogenic Differentiation from Human Periodontal Ligament FibroblastsMolecules and Cells, 2010
- cAMP/PKA Signaling Inhibits Osteogenic Differentiation and Bone Formation in Rodent ModelsTissue Engineering, Part A, 2009
- Membrane Potential Controls Adipogenic and Osteogenic Differentiation of Mesenchymal Stem CellsPLOS ONE, 2008
- cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivoProceedings of the National Academy of Sciences of the United States of America, 2008
- A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Inhibition of Histone Acetylation as a Tool in Bone Tissue EngineeringTissue Engineering, 2006
- Statistical practice in high-throughput screening data analysisNature Biotechnology, 2006
- Improved Statistical Methods for Hit Selection in High-Throughput ScreeningSLAS Discovery, 2003
- DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled waterAnalytical Biochemistry, 1990